The Peptide Field
Menu

Sources · 208 listed

Sources behind the answers.

Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.

Narrow the list

Filters

Showing 81–100 of 208 sources

Source types explained

Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.

81
Human pharmacologyPubMed · Journal of Clinical Endocrinology and Metabolism · 2026Checked 2026-08-30

Intermittent and continuous Kisspeptin-10 exposure in healthy men

Reviews using this sourceKisspeptin-10
Open source
82
Human pharmacologyPubMed · Journal of Clinical Endocrinology and Metabolism · 2015Checked 2026-08-30

Direct human comparison of Kisspeptin-10 and Kisspeptin-54

Reviews using this sourceKisspeptin-10
Open source
83
FDA reviewU.S. Food and Drug Administration · 2024Checked 2026-08-30

FDA identity overview for thymosin alpha-1

Reviews using this sourceThymosin alpha-1
Open source
84
FDA reviewU.S. Food and Drug Administration · 2025Checked 2026-08-30

FDA review of the separate thymosin beta-4 fragment called TB-500

Reviews using this sourceThymosin alpha-1TB-500
Open source
85
FDA reviewU.S. Food and Drug Administration · 2024Checked 2026-08-30

FDA evaluation of thymosin alpha-1 for pharmacy compounding

Reviews using this sourceThymosin alpha-1
Open source
88
Randomized trialPubMed · Critical Care · 2022Checked 2026-08-30

TRACE trial in acute pancreatitis

Reviews using this sourceThymosin alpha-1
Open source
90
Randomized trialPubMed · Hepatology · 1999Checked 2026-08-30

Randomized chronic hepatitis B trial

Reviews using this sourceThymosin alpha-1
Open source
91
Drug labelU.S. Food and Drug Administration · 2024Checked 2026-07-23

EGRIFTA SV (tesamorelin) prescribing information

Reviews using this sourceTesamorelin
Open source
92
Drug labelU.S. Food and Drug Administration · 2025Checked 2026-07-23

EGRIFTA WR (tesamorelin) prescribing information

Reviews using this sourceTesamorelin
Open source
93
Randomized trialPubMed · Journal of Acquired Immune Deficiency Syndromes · 2010Checked 2026-07-23

Tesamorelin in HIV-associated abdominal fat accumulation

Reviews using this sourceTesamorelin
Open source
94
FDA reviewU.S. Food and Drug Administration · 1991Checked 2026-07-23

Geref (sermorelin acetate) approval package

Reviews using this sourceSermorelin
Open source
95
RegulatoryFederal Register · U.S. Food and Drug Administration · 2013Checked 2026-07-23

FDA determination that Geref was not withdrawn for safety or effectiveness

Reviews using this sourceSermorelin
Open source
96
RegulatoryopenFDA · U.S. Food and Drug Administration · 2026Checked 2026-07-23

Current Drugs@FDA records for sermorelin

Reviews using this sourceSermorelin
Open source
97
Science reviewPubMed · BioDrugs · 1999Checked 2026-07-23

Sermorelin in diagnosis and treatment of pediatric growth hormone deficiency

Reviews using this sourceSermorelin
Open source
98
ReferenceU.S. Food and Drug Administration Global Substance Registration System · 2026Checked 2026-08-30

Gonadorelin substance identity record (UNII 9O7312W37G)

Reviews using this sourceGonadorelin
Open source
99
RegulatoryU.S. Food and Drug Administration · 1982Checked 2026-08-30

FACTREL (gonadorelin) Drugs@FDA record, NDA 018123

Reviews using this sourceGonadorelin
Open source
100
RegulatoryU.S. Food and Drug Administration · 1989Checked 2026-08-30

LUTREPULSE KIT (gonadorelin) Drugs@FDA record, NDA 019687

Reviews using this sourceGonadorelin
Open source

About this list

How this list works

This list includes sources used in the peptide reviews. Each source appears once, followed by the reviews that use it. Guide citations stay on their guide pages. A source here may support some claims, not every claim, about a peptide.